Bringing the fundamentals into focus…
Back to Bausch Health Companies Inc.
How Bausch Health Companies Inc. stacks up
BHC · against 1,336 other Healthcare companies
Valuation
56/ 100
Above the middle of the pack.
Ranked #583 of 1,337 · scores higher than 56% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 50–59, including BHC · Click a bar to see the companies
Why valuation scores 56?
Weighted metrics compared with all Healthcare companies.A mix: stronger free cash flow yield and EBITDA yield, but weaker earnings yield than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -36.1% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 94% of peers. EBITDA yield: 9.4% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 100% of peers. Free cash flow yield: 47.0% vs peer median 0.0%
Metric by metric
Position: dot = BHC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BHC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -27.8% | 1.5% | 10% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 18.7% | 4.2% | 94% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 60.0% | -1.0% | 100% | 20% | |
| Book yieldHigher is better · 1,306 reported | -43.6% | 37.9% | 2% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around BHCScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score